Synthetic Blood Protein Near Cure for Sickle Cell

Scientists at Columbia University have achieved a major breakthrough by learning to disassemble and reassemble human hemoglobin, the protein responsible for oxygen transport in the blood. This advancement overcomes a long-standing challenge in creating synthetic hemoglobin.

The new technique allows researchers to bind the protein chains with 'heme,' the iron-containing component of hemoglobin, without the chains falling apart. This ability to manipulate hemoglobin structure is crucial for understanding and potentially curing blood disorders like sickle-cell anemia.

While artificial hemoglobin cannot replace whole blood transfusions for immediate life support, this research opens new avenues for developing targeted therapies and treatments for various blood-related conditions. The findings are set to be presented to the American Chemical Society.